(October 18, 2023, 3:12 PM EDT) -- OKLAHOMA CITY — An Oklahoma federal judge overseeing cases involving claims that a company underfilled vials of the breast cancer drug Herceptin denied a motion filed by the plaintiffs to bifurcate class certification briefing....